Tissue Plasminogen Activator Market – Industry, Size, Analysis, 2018–2026

Tissue Plasminogen Activator Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND
OPPORTUNITY ANALYSIS, 2018-2026
REPORT DESCRIPTION
Tissue Plasminogen Activator Market – Overview
Tissue plasminogen activator (tPA) is an enzyme associated with the disintegration of blood clots. It is a serine
protease present in endothelial cells. With the help of serine protease, the conversion of plasminogen to plasmin is
catalyzed. Serine protease is a major enzyme for clot disintegration.
tPA is also be produced by using recombinant technology techniques known as recombinant tissue plasminogen
activator (rtPA). Specific rtPAs are tenecteplase, alteplase, and reteplase. These enzymes are used in clinical
treatment of thrombotic stroke or embolic stroke. tPA is a drug that dissolves blood clots. It is a thrombolytic
agent which can be administrated into the veins.
Tissue plasminogen activator is the first and only drug approved by the FDA in 1996 for the treatment of acute
ischemic stroke. Increasing incidences of stroke has boosted the tissue plasminogen activator market size.
According to John Hopkins Medicines (JHM) in the U.S., around 795,000 people in the U.S. suffer from stroke
per year, as reported in 2014. According to the World Health Organization (WHO), stroke is the second leading
cause of death and the third leading cause of disability, worldwide, as reported in 2012. This is one of the major
factors driving the tissue plasminogen activator market growth.
REPORT DESCRIPTION
Tissue Plasminogen Activator Market Taxonomy:
By Dosage
2mg
50mg
100mg
By Route of administration
Intravenous
Regional intra-arterial
By Application
Blood clots
Pulmonary embolism
Myocardial infarction
Stroke
Get Request a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/2469
REPORT DESCRIPTION
Tissue Plasminogen Activator Market – Key Players










Bayer AG
Abcam
Calbiochem
Merck & Company
Roche
Sekisui Diagnostics
Genentech
Sigma-Aldrich
Taj Pharmaceuticals
Cadila Healthcare Ltd
Get More Inf @
https://www.coherentmarketinsights.com/ongoing-insight/tissue-plasminogen-activator-market-2469
ABOUT COHERENT MARKET INSIGHTS
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its
plethora of clients achieve transformational growth by helping them make critical business decisions. We are
headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players
from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help
businesses around the globe deliver practical and lasting results through various recommendations about
operational improvements, technologies, emerging market trends and new working methods. We offer both
customized and syndicated market research reports that help our clients create visionary growth plans to
provide traction to their business. We meticulously study emerging trends across various industries at both the
global and regional levels to identify new opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
MARKET INTELLIGENCE SERVICES
CUSTOMIZED RESEARCH
CONSULT STUDIES
SYNDICATED RESEARCH
COUNTRY SPECIFIC STUDIES
ABOUT CMI
SECTOR
COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS







Global Leading Equipment and System Manufacturers
Component Providers and System Integrators
Distributors, Retailors and Value Added Resellers
Healthcare IT Solutions Developers
Marketing Consultancies and the Advertising Industry
Private and Government organization
Outsourcing Companies
ABOUT US
KEY STATS
RESEARCH
SOLUTIONS
FEASIBILITY
STUDIES
GLOBAL
REPORTS
100+
Insights Published Per Year
150+
Consulting Projects Till Date
125+
Clients Worldwide Per Year
110+
COUNTRY
ANALYSIS
CONSULT
PROJECTS
SURVEY
RESEARCH
EXCEL
FORECAST
DATABASE
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare,
and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports
across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique
—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our
clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities
posed therein.
THANK YOU
To know more about us, visit our website:
www.coherentmarketinsights.com
For sales queries or new topics email us on:
[email protected]
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
[email protected]
+1-206-701-6702

Tissue plasminogen activator is the first and only drug approved by the FDA in 1996 for the treatment of acute ischemic stroke.